Cancer Family
Malignant Respiratory System Neoplasm
CI-CAN-00000249Explore in graph →
2,648 active trials51 approved drugs619 evidence items
- NCIt
- C4571
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000249Explore in graph →
Clinical trials
11,125 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,490)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00095225 | A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer) | completed | Phase 2 | 122 | Genentech, Inc.INDUSTRY | 1 | Jan 29, 2008 | clinicaltrials |
| NCT00079794 | Iscar for Supplemental Care in Stage IV Lung Cancer | completed | Phase 2 | 36 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00080340 | Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer | completed | Phase 3 | 520 | TelikINDUSTRY | 8 | Jan 15, 2008 | clinicaltrials |
| NCT00328588 | LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy | completed | Phase 2 | 37 | Astellas Pharma IncINDUSTRY | 3 | Jan 2, 2008 | clinicaltrials |
| NCT00119470 | EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer | completed | Phase 2 | 40 | University Hospital, GhentOTHER | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00034346 | ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) | completed | Phase 2 | 194 | AmgenINDUSTRY | 0 | Dec 24, 2007 | clinicaltrials |
| NCT00089726 | A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 100 | Cell GenesysINDUSTRY | 0 | Dec 24, 2007 | clinicaltrials |
| NCT00120679 | Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Dec 24, 2007 | clinicaltrials |
| NCT00069875 | A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer | completed | Phase 2 | 195 | Eli Lilly and CompanyINDUSTRY | 6 | Dec 21, 2007 | clinicaltrials |
| NCT00578149 | Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer | completed | Phase 2 | 45 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00252798 | ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung Cancer | completed | Phase 1 | 44 | AstraZenecaINDUSTRY | 1 | Dec 19, 2007 | clinicaltrials |
| NCT00333294 | Phase II Iressa + Irradiation Followed by Chemo in NSCLC | completed | Phase 2 | 50 | AstraZenecaINDUSTRY | 1 | Dec 19, 2007 | clinicaltrials |
| NCT00252707 | Iressa 2nd Line Phase III Study in Japan | completed | Phase 3 | 484 | AstraZenecaINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00073151 | A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 30 | AbbottINDUSTRY | 1 | Nov 29, 2007 | clinicaltrials |
| NCT00259675 | Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC | completed | Phase 2 | 100 | University of SaskatchewanOTHER | 1 | Nov 15, 2007 | clinicaltrials |
| NCT00190710 | A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer | completed | Phase 3 | 242 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 14, 2007 | clinicaltrials |
| NCT00283478 | Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer | completed | N/A | 20 | Kentuckiana Cancer InstituteOTHER | 1 | Oct 31, 2007 | clinicaltrials |
| NCT00081315 | Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer | completed | Phase 2 | 130 | MedImmune LLCINDUSTRY | 1 | Aug 21, 2007 | clinicaltrials |
| NCT00173875 | Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer | completed | Phase 2 | 108 | National Taiwan University HospitalOTHER | 1 | Jul 30, 2007 | clinicaltrials |
| NCT00490659 | Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes | completed | Phase 2 | 13 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 25, 2007 | clinicaltrials |
| NCT00489983 | Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy | completed | Phase 2 | 91 | Eli Lilly and CompanyINDUSTRY | 3 | Jun 22, 2007 | clinicaltrials |
| NCT00489996 | Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer | completed | Phase 2 | 100 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 22, 2007 | clinicaltrials |
| NCT00080080 | Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | — | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00054795 | Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART) | completed | Phase 3 | 550 | Pharmacyclics LLC.INDUSTRY | 8 | May 8, 2007 | clinicaltrials |
| NCT00066885 | Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 80 | NovaceaINDUSTRY | 1 | May 7, 2007 | clinicaltrials |
| NCT00034827 | A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer | completed | Phase 2 | 172 | PfizerINDUSTRY | 1 | May 4, 2007 | clinicaltrials |
| NCT00105092 | Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer. | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | May 1, 2007 | clinicaltrials |
| NCT00188162 | Minimum Dose CT Post Lung Biopsy | completed | Phase 1 | 100 | University Health Network, TorontoOTHER | 1 | Apr 23, 2007 | clinicaltrials |
| NCT00464282 | Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer | completed | — | — | Gunma UniversityOTHER | 0 | Apr 23, 2007 | clinicaltrials |
| NCT00440960 | Anesthesia in Flexible Bronchoscopy for Lung Cancer Diagnostic | completed | Phase 4 | — | Hospital PompeiaOTHER | 1 | Feb 27, 2007 | clinicaltrials |
| NCT00061464 | Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy. | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00190840 | A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 186 | Eli Lilly and CompanyINDUSTRY | 8 | Jan 26, 2007 | clinicaltrials |
| NCT00191230 | Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191256 | Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer | completed | Phase 2 | 77 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191490 | A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer | completed | Phase 2 | 162 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191620 | Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer. | completed | Phase 2 | 64 | Eli Lilly and CompanyINDUSTRY | 4 | Jan 26, 2007 | clinicaltrials |
| NCT00260026 | Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer | completed | Phase 2 | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00179686 | A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer | completed | Phase 2 | 40 | Celgene CorporationINDUSTRY | 1 | Dec 20, 2006 | clinicaltrials |
| NCT00407264 | Randomized Trial of Fluticasone in Bronchial Premalignancy | completed | Phase 2 | 90 | Amsterdam UMC, location VUmcOTHER | 1 | Dec 4, 2006 | clinicaltrials |
| NCT00174356 | PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients | completed | Phase 1 | 39 | PfizerINDUSTRY | 2 | Nov 8, 2006 | clinicaltrials |
| NCT00191841 | Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 24, 2006 | clinicaltrials |
| NCT00034268 | A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 21 | Jul 19, 2006 | clinicaltrials |
| NCT00034606 | Comparing 3 Schedules of Alimta Plus Gemzar | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00042679 | A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00051493 | ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00144053 | A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer | completed | Phase 3 | 450 | West Japan Thoracic Oncology GroupOTHER | 0 | Jan 6, 2006 | clinicaltrials |
| NCT00148291 | Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 3 | 180 | West Japan Thoracic Oncology GroupOTHER | 0 | Jan 6, 2006 | clinicaltrials |
| NCT00130143 | Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities | completed | N/A | 20 | The Dale & Frances Hughes Cancer CenterOTHER | 1 | Sep 27, 2005 | clinicaltrials |
| NCT00175747 | A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) | completed | Phase 2 / Phase 3 | 120 | University of British ColumbiaOTHER | 1 | Sep 15, 2005 | clinicaltrials |
| NCT00166972 | Molecular Mechanism of Trophinin in Cancer Invasion and Metastasis | completed | — | 150 | National Taiwan University HospitalOTHER | 0 | Sep 14, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Jan 29, 2008source: clinicaltrials